Study links another gene variant to male breast cancer

September 23, 2012 by Randy Dotinga, Healthday Reporter
Study links another gene variant to male breast cancer
Finding offers insight into causes of disease that kills several hundred men in US each year.

(HealthDay)—Researchers report that they've identified another genetic variation that appears connected to male breast cancer, a rare condition that kills several hundred men in the United States each year.

The finding won't immediately lead to any improvements in treatment for the disease. Still, "by finding more male , we can understand more about the biology of the disease and, as a result, get a better understanding of how best to treat ," said study author Dr. Nick Orr, a team leader at the Institute of in London. "We hope these findings will also help us to learn more about how the disease works in women, too."

Male breast cancer is about 100 times less common than female breast cancer, according to the . It estimates that this year breast cancer will be diagnosed in about 2,190 men in the United States and will kill about 410 men.

The prognosis for men with breast cancer is similar to that for women with breast cancer, although less is known about the disease in men. A study released last year also found that men are diagnosed on average at an older age (70) than women (62).

"We've made a lot of progress in finding causes of breast cancer in women over the past couple of decades," Orr explained. "But we know very little about what causes the disease in men."

In the new study, researchers examined the DNA of 823 men with breast cancer and 2,795 similar men without the disease. They then attempted to validate their results by looking at the genes of 438 men with the disease and 474 similar men without it.

Orr said his team found that a variation in a gene known as RAD51B was found in 20 percent of the men with breast cancer, but only 15 percent of those without it. The variation has also been linked to female breast cancer.

The findings add to previous research that has linked in a gene known as to a higher rate of breast cancer in men. Mutations in the gene greatly boost the risk of breast cancer in women.

For now, the findings are useful in terms of understanding the disease, said Dr. Mikael Hartman, an assistant professor at National University of Singapore. "The ultimate goal is prevention, but that is a long way ahead. Thus, any preventive treatment will have to wait."

While it's helpful to know which genes are connected to the disease, he said, "the ability of these markers to predict is so far only marginally better than flipping a coin. When hopefully hundreds of these markers are identified, we could consider making predictions based on an individual's genetic makeup."

The study is published online Sept. 23 in the journal Nature Genetics.

Explore further: Researchers call for more awareness of male breast cancer as cases rise

More information: For more about male breast cancer, see the U.S. National Library of Medicine.

Paper: DOI: 10.1038/ng.2417

Related Stories

Researchers call for more awareness of male breast cancer as cases rise

October 3, 2011
(Medical Xpress) -- Awareness of male breast cancer is low and most men do not even know they are at risk despite an increase in cases, reveals new research from the University of Leeds.

PSA test for men could get a second life for breast cancer in women

July 13, 2011
The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ...

Breast cancer type linked to paternal cancer

November 28, 2011
The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.